• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病中的蛋白质信号传导与基因转录调控:酪蛋白激酶II - Ikaros轴的作用

Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.

作者信息

Gowda Chandrika S, Song Chunhua, Ding Yali, Kapadia Malika, Dovat Sinisa

机构信息

Department of Pediatrics, Penn State University College of Medicine, Hershey, Pennsylvania, USA.

出版信息

J Investig Med. 2016 Mar;64(3):735-9. doi: 10.1136/jim-2016-000075. Epub 2016 Feb 9.

DOI:10.1136/jim-2016-000075
PMID:26912004
Abstract

Protein signaling and regulation of gene expression are the two major mechanisms that regulate cellular proliferation in leukemia. Discerning the function of these processes is essential for understanding the pathogenesis of leukemia and for developing the targeted therapies. Here, we provide an overview of one of the mechanisms that regulates gene transcription in leukemia. This mechanism involves the direct interaction between Casein Kinase II (CK2) and the Ikaros transcription factor. Ikaros (IKZF1) functions as a master regulator of hematopoiesis and a tumor suppressor in acute lymphoblastic leukemia (ALL). Impaired Ikaros function results in the development of high-risk leukemia. Ikaros binds to the upstream regulatory elements of its target genes and regulates their transcription via chromatin remodeling. In vivo, Ikaros is a target for CK2, a pro-oncogenic kinase. CK2 directly phosphorylates Ikaros at multiple amino acids. Functional experiments showed that CK2-mediated phosphorylation of Ikaros, regulates Ikaros' DNA binding affinity, subcellular localization and protein stability. Recent studies revealed that phosphorylation of Ikaros by CK2 regulates Ikaros binding and repression of the terminal deoxytransferase (TdT) gene in normal thymocytes and in T-cell ALL. Available data suggest that the oncogenic activity of CK2 in leukemia involves functional inactivation of Ikaros and provide a rationale for CK2 inhibitors as a potential treatment for ALL.

摘要

蛋白质信号传导和基因表达调控是调节白血病细胞增殖的两个主要机制。辨别这些过程的功能对于理解白血病的发病机制和开发靶向治疗方法至关重要。在此,我们概述白血病中调节基因转录的机制之一。该机制涉及酪蛋白激酶II(CK2)与Ikaros转录因子之间的直接相互作用。Ikaros(IKZF1)在急性淋巴细胞白血病(ALL)中作为造血的主要调节因子和肿瘤抑制因子发挥作用。Ikaros功能受损会导致高危白血病的发生。Ikaros与其靶基因的上游调控元件结合,并通过染色质重塑调节其转录。在体内,Ikaros是原癌基因激酶CK2的作用靶点。CK2直接在多个氨基酸位点磷酸化Ikaros。功能实验表明,CK2介导的Ikaros磷酸化调节Ikaros的DNA结合亲和力、亚细胞定位和蛋白质稳定性。最近的研究表明,在正常胸腺细胞和T细胞ALL中,CK2对Ikaros的磷酸化调节Ikaros与末端脱氧转移酶(TdT)基因的结合及抑制作用。现有数据表明,CK2在白血病中的致癌活性涉及Ikaros的功能失活,并为CK2抑制剂作为ALL的潜在治疗方法提供了理论依据。

相似文献

1
Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.白血病中的蛋白质信号传导与基因转录调控:酪蛋白激酶II - Ikaros轴的作用
J Investig Med. 2016 Mar;64(3):735-9. doi: 10.1136/jim-2016-000075. Epub 2016 Feb 9.
2
Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.Ikaros、组蛋白去乙酰化酶1(HDAC1)和酪蛋白激酶2(CK2)对B细胞急性淋巴细胞白血病中JARID1B/KDM5B组蛋白去甲基化酶的转录调控
J Biol Chem. 2016 Feb 19;291(8):4004-18. doi: 10.1074/jbc.M115.679332. Epub 2015 Dec 10.
3
Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.蛋白磷酸酶1(PP1)和酪蛋白激酶II(CK2)调节Ikaros介导的胸腺细胞和T细胞白血病中末端脱氧核苷酸转移酶(TdT)的抑制作用。
Pediatr Blood Cancer. 2014 Dec;61(12):2230-5. doi: 10.1002/pbc.25221. Epub 2014 Sep 11.
4
Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.酪蛋白激酶II(CK2)、糖原合酶激酶-3(GSK-3)与伊卡洛斯介导的白血病调控
Adv Biol Regul. 2017 Aug;65:16-25. doi: 10.1016/j.jbior.2017.06.001. Epub 2017 Jun 13.
5
Ikaros, CK2 kinase, and the road to leukemia.Ikaros、CK2 激酶与白血病之路。
Mol Cell Biochem. 2011 Oct;356(1-2):201-7. doi: 10.1007/s11010-011-0964-5. Epub 2011 Jul 13.
6
Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.IKAROS 和蛋白激酶 CK2 对 T 细胞急性淋巴细胞白血病中 PIK3CD 和 PIKFYVE 的转录调控。
Int J Mol Sci. 2021 Jan 15;22(2):819. doi: 10.3390/ijms22020819.
7
Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.酪蛋白激酶II(CK2)和Ikaros对急性淋巴细胞白血病细胞增殖的调控
Adv Biol Regul. 2017 Jan;63:71-80. doi: 10.1016/j.jbior.2016.09.003. Epub 2016 Sep 18.
8
Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.靶向酪蛋白激酶II可恢复Ikaros肿瘤抑制活性,并在高危白血病中显示出治疗效果。
Blood. 2015 Oct 8;126(15):1813-22. doi: 10.1182/blood-2015-06-651505. Epub 2015 Jul 28.
9
Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.Ikaros 肿瘤抑制因子对急性淋巴细胞白血病中基因的转录调控。
Int J Mol Sci. 2020 Feb 18;21(4):1377. doi: 10.3390/ijms21041377.
10
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.IKAROS 和 CK2 调节高危 B 细胞急性淋巴细胞白血病中 BCL-XL 的表达和化疗敏感性。
Blood. 2020 Sep 24;136(13):1520-1534. doi: 10.1182/blood.2019002655.

引用本文的文献

1
Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL.通过CK2/IKAROS轴靶向WDR5/ATAD2信号传导在T细胞急性淋巴细胞白血病中显示出治疗效果。
Blood. 2025 Mar 27;145(13):1407-1421. doi: 10.1182/blood.2024024130.
2
CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.患有急性淋巴细胞白血病和复发性基因融合的墨西哥儿童中的CRLF2和IKZF1异常:探索信号通路的替代标志物
J Pathol Clin Res. 2021 Jul;7(4):410-421. doi: 10.1002/cjp2.211. Epub 2021 Apr 23.
3
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
双重靶向 MTOR 作为高危 B 细胞急性淋巴细胞白血病的一种新治疗方法。
Leukemia. 2021 May;35(5):1267-1278. doi: 10.1038/s41375-021-01132-5. Epub 2021 Feb 2.
4
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.IKAROS 和 CK2 调节高危 B 细胞急性淋巴细胞白血病中 BCL-XL 的表达和化疗敏感性。
Blood. 2020 Sep 24;136(13):1520-1534. doi: 10.1182/blood.2019002655.
5
Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.Ikaros 对 B 细胞急性淋巴细胞白血病中小 GTPase Rab20 的调控作用。
Int J Mol Sci. 2020 Mar 3;21(5):1718. doi: 10.3390/ijms21051718.
6
Cellular signaling and epigenetic regulation of gene expression in leukemia.白血病中基因表达的细胞信号转导和表观遗传调控。
Adv Biol Regul. 2020 Jan;75:100665. doi: 10.1016/j.jbior.2019.100665. Epub 2019 Oct 5.
7
Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.酪蛋白激酶II(CK2)、糖原合酶激酶-3(GSK-3)与伊卡洛斯介导的白血病调控
Adv Biol Regul. 2017 Aug;65:16-25. doi: 10.1016/j.jbior.2017.06.001. Epub 2017 Jun 13.
8
Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.酪蛋白激酶II(CK2)和Ikaros对急性淋巴细胞白血病细胞增殖的调控
Adv Biol Regul. 2017 Jan;63:71-80. doi: 10.1016/j.jbior.2016.09.003. Epub 2016 Sep 18.